Logo image of XOS

XOS INC (XOS) Stock Fundamental Analysis

NASDAQ:XOS - Nasdaq - US98423B3069 - Common Stock - Currency: USD

3.38  +0.16 (+4.97%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to XOS. XOS was compared to 128 industry peers in the Machinery industry. XOS may be in some trouble as it scores bad on both profitability and health. XOS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

XOS had negative earnings in the past year.
XOS had a negative operating cash flow in the past year.
In the past 5 years XOS reported 4 times negative net income.
XOS had a negative operating cash flow in each of the past 5 years.
XOS Yearly Net Income VS EBIT VS OCF VS FCFXOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

With a Return On Assets value of -51.01%, XOS is not doing good in the industry: 89.84% of the companies in the same industry are doing better.
The Return On Equity of XOS (-149.24%) is worse than 88.28% of its industry peers.
Industry RankSector Rank
ROA -51.01%
ROE -149.24%
ROIC N/A
ROA(3y)-56.86%
ROA(5y)-56.23%
ROE(3y)-127.49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XOS Yearly ROA, ROE, ROICXOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300 -400

1.3 Margins

XOS has a Gross Margin of 7.09%. This is amonst the worse of the industry: XOS underperforms 90.63% of its industry peers.
XOS's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for XOS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-24.85%
XOS Yearly Profit, Operating, Gross MarginsXOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

3

2. Health

2.1 Basic Checks

XOS does not have a ROIC to compare to the WACC, probably because it is not profitable.
XOS has more shares outstanding than it did 1 year ago.
XOS has less shares outstanding than it did 5 years ago.
XOS has a better debt/assets ratio than last year.
XOS Yearly Shares OutstandingXOS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
XOS Yearly Total Debt VS Total AssetsXOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -3.18, we must say that XOS is in the distress zone and has some risk of bankruptcy.
XOS's Altman-Z score of -3.18 is on the low side compared to the rest of the industry. XOS is outperformed by 87.50% of its industry peers.
XOS has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.01, XOS belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -3.18
ROIC/WACCN/A
WACC9.28%
XOS Yearly LT Debt VS Equity VS FCFXOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

XOS has a Current Ratio of 1.76. This is a normal value and indicates that XOS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of XOS (1.76) is worse than 64.84% of its industry peers.
XOS has a Quick Ratio of 1.76. This is a bad value and indicates that XOS is not financially healthy enough and could expect problems in meeting its short term obligations.
XOS has a Quick ratio of 0.98. This is in the lower half of the industry: XOS underperforms 67.97% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 0.98
XOS Yearly Current Assets VS Current LiabilitesXOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

XOS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 53.47%, which is quite impressive.
The Revenue has grown by 25.68% in the past year. This is a very strong growth!
XOS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 117.49% yearly.
EPS 1Y (TTM)53.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1.29%
Revenue 1Y (TTM)25.68%
Revenue growth 3Y122.95%
Revenue growth 5Y117.49%
Sales Q2Q%-37.56%

3.2 Future

The Earnings Per Share is expected to grow by 11.82% on average over the next years. This is quite good.
The Revenue is expected to grow by 7.71% on average over the next years.
EPS Next Y35.71%
EPS Next 2Y25.14%
EPS Next 3Y11.82%
EPS Next 5YN/A
Revenue Next Year-7.51%
Revenue Next 2Y12.96%
Revenue Next 3Y6.86%
Revenue Next 5Y7.71%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
XOS Yearly Revenue VS EstimatesXOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M
XOS Yearly EPS VS EstimatesXOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XOS. In the last year negative earnings were reported.
Also next year XOS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XOS Price Earnings VS Forward Price EarningsXOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XOS Per share dataXOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.14%
EPS Next 3Y11.82%

More info and screens

0

5. Dividend

5.1 Amount

XOS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XOS INC

NASDAQ:XOS (4/17/2025, 8:00:02 PM)

3.38

+0.16 (+4.97%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)03-28 2025-03-28/amc
Earnings (Next)05-13 2025-05-13/amc
Inst Owners2.8%
Inst Owner Change-0.01%
Ins Owners25.03%
Ins Owner Change-0.05%
Market Cap27.38M
Analysts80
Price Target9.44 (179.29%)
Short Float %17.41%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-32.63%
Min EPS beat(2)-97.18%
Max EPS beat(2)31.92%
EPS beat(4)3
Avg EPS beat(4)1.21%
Min EPS beat(4)-97.18%
Max EPS beat(4)49.25%
EPS beat(8)4
Avg EPS beat(8)-4.64%
EPS beat(12)7
Avg EPS beat(12)0.83%
EPS beat(16)9
Avg EPS beat(16)0.44%
Revenue beat(2)0
Avg Revenue beat(2)-33.78%
Min Revenue beat(2)-36.13%
Max Revenue beat(2)-31.44%
Revenue beat(4)0
Avg Revenue beat(4)-22.92%
Min Revenue beat(4)-36.13%
Max Revenue beat(4)-7.02%
Revenue beat(8)2
Avg Revenue beat(8)-17.83%
Revenue beat(12)4
Avg Revenue beat(12)-11.65%
Revenue beat(16)5
Avg Revenue beat(16)-17.69%
PT rev (1m)-5.13%
PT rev (3m)-5.13%
EPS NQ rev (1m)-1.74%
EPS NQ rev (3m)-1.74%
EPS NY rev (1m)-0.62%
EPS NY rev (3m)-0.62%
Revenue NQ rev (1m)-42.88%
Revenue NQ rev (3m)-49.79%
Revenue NY rev (1m)-43.78%
Revenue NY rev (3m)-43.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.49
P/FCF N/A
P/OCF N/A
P/B 0.81
P/tB 0.81
EV/EBITDA N/A
EPS(TTM)-6.11
EYN/A
EPS(NY)-3.93
Fwd EYN/A
FCF(TTM)-6.06
FCFYN/A
OCF(TTM)-6.02
OCFYN/A
SpS6.91
BVpS4.15
TBVpS4.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -51.01%
ROE -149.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.09%
FCFM N/A
ROA(3y)-56.86%
ROA(5y)-56.23%
ROE(3y)-127.49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-24.85%
F-Score5
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.09%
Cap/Sales 0.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 0.98
Altman-Z -3.18
F-Score5
WACC9.28%
ROIC/WACCN/A
Cap/Depr(3y)244.18%
Cap/Depr(5y)306.81%
Cap/Sales(3y)14.15%
Cap/Sales(5y)31.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1.29%
EPS Next Y35.71%
EPS Next 2Y25.14%
EPS Next 3Y11.82%
EPS Next 5YN/A
Revenue 1Y (TTM)25.68%
Revenue growth 3Y122.95%
Revenue growth 5Y117.49%
Sales Q2Q%-37.56%
Revenue Next Year-7.51%
Revenue Next 2Y12.96%
Revenue Next 3Y6.86%
Revenue Next 5Y7.71%
EBIT growth 1Y29.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year47.4%
EBIT Next 3Y14.31%
EBIT Next 5Y7.86%
FCF growth 1Y-20.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.2%
OCF growth 3YN/A
OCF growth 5YN/A